A pharmaceutical target has been identified by Duke University that, when activated, can reverse bone degradation caused by osteoporosis.
List view / Grid view
Filter the results
Scientists in the U.S. have reported findings about the mechanisms that contribute to the experience of weaker bones with age.
In a preclinical study in mice and human cells, researchers report that selectively removing old or 'senescent' cells from joints could stop and even reverse the progression of osteoarthritis.
Researchers from UPM and CSIC have employed waste from the agri-food industry to develop biomaterials that are able to act as matrices to regenerate bone and cartilage tissues, which is of great interest for the treatment of diseases related to ageing.